3P
Desconocido
TARGETAMD: Transposon based targeted ex vivo gene therapy to treat age related macular degeneration AMD
3P BIOPHARMACEUTICALS SL
participó en un
FP7:
Age-related Macular Degeneration (AMD), a neurodegenerative disease of the retina, is a major cause of blindness in elderly people. Due to t...
Financiado
Financiado
FLUTCORE: Development of a universal influenza vaccine based on tandem core technology
3P BIOPHARMACEUTICALS SL
participó en un
FP7:
FLUTCORE will develop a novel universal influenza A virus (IAV) vaccine based on the tandem core vaccine platform. Recent influenza pandemic...
Financiado
Financiado
* No se disponen de datos de la empresa actual.